Skip to main content

Advertisement

Log in

Increased pro-inflammatory cytokine gene expression in peripheral blood mononuclear cells of patients with polyneuropathies

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Background

Distinct cytokine expression patterns have been reported in biomaterial of patients with polyneuropathies (PNP). We investigated gene expression profiles of pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells (PBMC) of patients with neuropathies of different etiologies.

Methods

We prospectively studied 97 patients with neuropathies and compared data between diagnostic subgroups and healthy controls. Gene expression of a panel of pro- and anti-inflammatory cytokines was analyzed (interleukin-1 [IL-1], IL-2, IL-6, IL-8, tumor necrosis factor alpha [TNF], IL-4, and IL-10) in PBMC samples. Furthermore, protein levels of IL-6, IL-8, and TNF were measured in supernatant of PBMC stimulated with lipopolysaccharide (LPS).

Results

PNP were associated with higher PBMC gene expression of IL-1 (p < 0.05), IL-2 (p < 0.05), IL-8 (p < 0.001), and TNF (p < 0.01) compared to healthy controls. Inflammatory neuropathies were associated with higher gene expression of IL-8 (p < 0.001) and TNF (p < 0.05) and lower gene expression of IL-10 (p < 0.05) compared to healthy controls. More pro-inflammatory cytokines were elevated in painful neuropathy (IL-1, IL-2 [p < 0.05], IL-8 [p < 0.001] and TNF [p < 0.05]) than in painless neuropathy (IL-8 [p < 0.01] and TNF [p < 0.01]) compared to healthy controls, while IL-10 expression was higher in treatment naïve patients with painless neuropathy compared to patients with painful neuropathy (p < 0.05). Disease duration positively correlated with IL-6 gene expression (p < 0.01). Supernatant protein levels of IL-6, IL-8, and TNF did not differ between groups.

Conclusion

Systemic gene expression of pro-inflammatory cytokines is increased in patients with neuropathies and may be influenced by the presence of neuropathic pain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. DeFrancesco-Lisowitz A, Lindborg JA, Niemi JP, Zigmond RE (2015) The neuroimmunology of degeneration and regeneration in the peripheral nervous system. Neuroscience 302:174–203

    Article  CAS  PubMed  Google Scholar 

  2. Nadeau S, Filali M, Zhang J, Kerr BJ, Rivest S, Soulet D, Iwakura Y, de Rivero Vaccari JP, Keane RW, Lacroix S (2011) Functional recovery after peripheral nerve injury is dependent on the pro-inflammatory cytokines IL-1beta and TNF: implications for neuropathic pain. J Neurosci 31:12533–12542

    Article  CAS  PubMed  Google Scholar 

  3. Austin PJ, Moalem-Taylor G (2010) The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neuroimmunol 229:26–50

    Article  CAS  PubMed  Google Scholar 

  4. Lees JG, Fivelman B, Duffy SS, Makker PG, Perera CJ, Moalem-Taylor G (2015) Cytokines in neuropathic pain and associated depression. Mod Trends Pharmacopsychiatr 30:51–66

    Article  Google Scholar 

  5. Brannagan TH 3rd (2011) Current diagnosis of CIDP: the need for biomarkers. J Peripher Nerv Syst 16(Suppl 1):3–13

    Article  PubMed  Google Scholar 

  6. Latov N (2011) Biomarkers of CIDP in patients with diabetes or CMT1. J Peripher Nerv Syst 16(Suppl 1):14–17

    Article  PubMed  Google Scholar 

  7. Üçeyler N, Riediger N, Kafke W, Sommer C (2015) Differential gene expression of cytokines and neurotrophic factors in nerve and skin of patients with peripheral neuropathies. J Neurol 262:203–212

    Article  PubMed  Google Scholar 

  8. Gironi M, Saresella M, Marventano I, Guerini FR, Gatti A, Antonini G, Ceresa L, Morino S, Beghi E, Angelici A, Mariani E, Nemni R, Clerici M (2010) Distinct cytokine patterns associated with different forms of chronic dysimmune neuropathy. Muscle Nerve 42:864–870

    Article  CAS  PubMed  Google Scholar 

  9. Beppu M, Sawai S, Misawa S, Sogawa K, Mori M, Ishige T, Satoh M, Nomura F, Kuwabara S (2015) Serum cytokine and chemokine profiles in patients with chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 279:7–10

    Article  CAS  PubMed  Google Scholar 

  10. Üçeyler N, Rogausch JP, Toyka KV, Sommer C (2007) Differential expression of cytokines in painful and painless neuropathies. Neurology 69:42–49

    Article  PubMed  Google Scholar 

  11. Backonja MM, Coe CL, Muller DA, Schell K (2008) Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients. J Neuroimmunol 195:157–163

    Article  CAS  PubMed  Google Scholar 

  12. Hougee S, Sanders A, Faber J, Graus YM, van den Berg WB, Garssen J, Smit HF, Hoijer MA (2005) Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/macrophages. Biochem Pharmacol 69:241–248

    Article  CAS  PubMed  Google Scholar 

  13. Merkies IS, Schmitz PI, van der Meche FG, Samijn JP, van Doorn PA, Inflammatory Neuropathy C, Treatment G (2003) Connecting impairment, disability, and handicap in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 74:99–104

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, Rostaing S, Lanteri-Minet M, Collin E, Grisart J, Boureau F (2004) Development and validation of the Neuropathic Pain Symptom Inventory. Pain 108:248–257

    Article  PubMed  Google Scholar 

  15. Sommer C, Richter H, Rogausch JP, Frettloh J, Lungenhausen M, Maier C (2011) A modified score to identify and discriminate neuropathic pain: a study on the German version of the Neuropathic Pain Symptom Inventory (NPSI). BMC Neurol 11:104

    Article  PubMed  PubMed Central  Google Scholar 

  16. Von Korff M, Ormel J, Keefe FJ, Dworkin SF (1992) Grading the severity of chronic pain. Pain 50:133–149

    Article  Google Scholar 

  17. Hautzinger M, Bailer M (1993) Allgemeine Depressionsskala. Manual Weinheim Beltz Gesellschaft, Weinheim

    Google Scholar 

  18. Vrancken AF, Notermans NC, Jansen GH, Wokke JH, Said G (2004) Progressive idiopathic axonal neuropathy–a comparative clinical and histopathological study with vasculitic neuropathy. J Neurol 251:269–278

    Article  PubMed  Google Scholar 

  19. Hughes RA (2001) Chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50:281–282

    Article  CAS  PubMed  Google Scholar 

  20. Ayrignac X, Viala K, Koutlidis RM, Taieb G, Stojkovic T, Musset L, Leger JM, Fournier E, Maisonobe T, Bouche P (2013) Sensory chronic inflammatory demyelinating polyneuropathy: an under-recognized entity? Muscle Nerve 48:727–732

    Article  PubMed  Google Scholar 

  21. Eftimov F, van Schaik I (2013) Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options. Curr Opin Neurol 26:496–502

    Article  CAS  PubMed  Google Scholar 

  22. Lewis RA, Sumner AJ, Brown MJ, Asbury AK (1982) Multifocal demyelinating neuropathy with persistent conduction block. Neurology 32:958–964

    Article  CAS  PubMed  Google Scholar 

  23. Saperstein DS, Amato AA, Wolfe GI, Katz JS, Nations SP, Jackson CE, Bryan WW, Burns DK, Barohn RJ (1999) Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve 22:560–566

    Article  PubMed  Google Scholar 

  24. Joint Task Force of the E, the PNS (2010) European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society–first revision. J Peripher Nerv Syst 15:185–195

    Article  Google Scholar 

  25. Devigili G, Tugnoli V, Penza P, Camozzi F, Lombardi R, Melli G, Broglio L, Granieri E, Lauria G (2008) The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 131:1912–1925

    Article  PubMed  PubMed Central  Google Scholar 

  26. Lacomis D (2002) Small-fiber neuropathy. Muscle Nerve 26:173–188

    Article  PubMed  Google Scholar 

  27. Collins MP, Periquet MI, Mendell JR, Sahenk Z, Nagaraja HN, Kissel JT (2003) Nonsystemic vasculitic neuropathy: insights from a clinical cohort. Neurology 61:623–630

    Article  CAS  PubMed  Google Scholar 

  28. Üçeyler N, Geng A, Reiners K, Toyka KV, Sommer C (2015) Non-systemic vasculitic neuropathy: single-center follow-up of 60 patients. J Neurol 262:2092–2100

    Article  PubMed  Google Scholar 

  29. Furukawa T, Matsui N, Fujita K, Miyashiro A, Nodera H, Izumi Y, Shimizu F, Miyamoto K, Takahashi Y, Kanda T, Kusunoki S, Kaji R (2014) Increased proinflammatory cytokines in sera of patients with multifocal motor neuropathy. J Neurol Sci 346:75–79

    Article  CAS  PubMed  Google Scholar 

  30. Doupis J, Lyons TE, Wu S, Gnardellis C, Dinh T, Veves A (2009) Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metab 94:2157–2163

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Vincent AM, Callaghan BC, Smith AL, Feldman EL (2011) Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol 7:573–583

    Article  CAS  PubMed  Google Scholar 

  32. Ludwig J, Binder A, Steinmann J, Wasner G, Baron R (2008) Cytokine expression in serum and cerebrospinal fluid in non-inflammatory polyneuropathies. J Neurol Neurosurg Psychiatry 79:1268–1273

    Article  CAS  PubMed  Google Scholar 

  33. Üçeyler N, Kafke W, Riediger N, He L, Necula G, Toyka KV, Sommer C (2010) Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy. Neurology 74:1806–1813

    Article  PubMed  Google Scholar 

  34. Empl M, Renaud S, Erne B, Fuhr P, Straube A, Schaeren-Wiemers N, Steck AJ (2001) TNF-alpha expression in painful and nonpainful neuropathies. Neurology 56:1371–1377

    Article  CAS  PubMed  Google Scholar 

  35. Lindenlaub T, Sommer C (2003) Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol 105:593–602

    CAS  PubMed  Google Scholar 

  36. Kinter J, Broglio L, Steck AJ, Tolnay M, Fuhr P, Latov N, Kalbermatten D, Sinnreich M, Schaeren-Wiemers N, Renaud S (2010) Gene expression profiling in nerve biopsy of vasculitic neuropathy. J Neuroimmunol 225:184–189

    Article  CAS  PubMed  Google Scholar 

  37. Renaud S, Hays AP, Brannagan TH 3rd, Sander HW, Edgar M, Weimer LH, Olarte MR, Dalakas MC, Xiang Z, Danon MJ, Latov N (2005) Gene expression profiling in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 159:203–214

    Article  CAS  PubMed  Google Scholar 

  38. Steck AJ, Kinter J, Renaud S (2011) Differential gene expression in nerve biopsies of inflammatory neuropathies. J Peripher Nerv Syst 16(Suppl 1):30–33

    Article  PubMed  Google Scholar 

  39. Maingret F, Coste B, Padilla F, Clerc N, Crest M, Korogod SM, Delmas P (2008) Inflammatory mediators increase Nav1.9 current and excitability in nociceptors through a coincident detection mechanism. J Gen Physiol 131:211–225

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Martini R, Willison H (2016) Neuroinflammation in the peripheral nerve: cause, modulator, or bystander in peripheral neuropathies? Glia 64:475–486

    Article  PubMed  Google Scholar 

  41. Murphy PG, Ramer MS, Borthwick L, Gauldie J, Richardson PM, Bisby MA (1999) Endogenous interleukin-6 contributes to hypersensitivity to cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice. Eur J Neurosci 11:2243–2253

    Article  CAS  PubMed  Google Scholar 

  42. Zigmond RE, Hyatt-Sachs H, Mohney RP, Schreiber RC, Shadiack AM, Sun Y, Vaccariello SA (1996) Changes in neuropeptide phenotype after axotomy of adult peripheral neurons and the role of leukemia inhibitory factor. Perspect Dev Neurobiol 4:75–90

    CAS  PubMed  Google Scholar 

  43. Cameron NE, Cotter MA (2007) The neurocytokine, interleukin-6, corrects nerve dysfunction in experimental diabetes. Exp Neurol 207:23–29

    Article  CAS  PubMed  Google Scholar 

  44. Koike H, Iijima M, Mori K, Yamamoto M, Hattori N, Watanabe H, Tanaka F, Doyu M, Sobue G (2008) Neuropathic pain correlates with myelinated fibre loss and cytokine profile in POEMS syndrome. J Neurol Neurosurg Psychiatry 79:1171–1179

    Article  CAS  PubMed  Google Scholar 

  45. Corkum CP, Ings DP, Burgess C, Karwowska S, Kroll W, Michalak TI (2015) Immune cell subsets and their gene expression profiles from human PBMC isolated by Vacutainer Cell Preparation Tube (CPT) and standard density gradient. BMC Immunol 16:48

    Article  PubMed  PubMed Central  Google Scholar 

  46. Luchting B, Rachinger-Adam B, Heyn J, Hinske LC, Kreth S, Azad SC (2015) Anti-inflammatory T-cell shift in neuropathic pain. J Neuroinflamm 12:12

    Article  Google Scholar 

  47. Yang M, Peyret C, Shi XQ, Siron N, Jang JH, Wu S, Fournier S, Zhang J (2015) Evidence from human and animal studies: pathological roles of CD8(+) T cells in autoimmune peripheral neuropathies. Front Immunol 6:532

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Expert technical help by S. Mildner is gratefully acknowledged. The study was supported by intramural funds of the University of Würzburg. This work is part of the doctoral thesis of M. Langjahr.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nurcan Üçeyler.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical standards

All human studies must state that they have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Langjahr, M., Schubert, AL., Sommer, C. et al. Increased pro-inflammatory cytokine gene expression in peripheral blood mononuclear cells of patients with polyneuropathies. J Neurol 265, 618–627 (2018). https://doi.org/10.1007/s00415-018-8748-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-018-8748-4

Keywords

Navigation